The use of p16 as a surrogate marker for HPV has gained traction, but is it sufficient as a surrogate for HPV-related squamous cell carcinoma?
The use of p16 as a surrogate marker for HPV has gained traction, but is it sufficient as a surrogate for HPV-related squamous cell carcinoma?